GPCR - CIK 0001888886
The table below shows Structure Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $316.17M | $102.91M | $147.02M | $152.12M | $172.13M | $381.63M |
| Short-term investments | $1.14B | $696.13M | $639.47M | $684.76M | $743.16M | $545.49M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.49B |
| $814.02M |
| $799.30M |
| $849.62M |
| $923.65M |
| $937.62M |
| Property, plant & equipment | $6.37M | $4.67M | $3.46M | $3.52M | $3.73M | $3.31M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.51B | $832.16M | $816.44M | $866.55M | $933.22M | $947.03M |
| Accounts payable | $7.82M | $17.80M | $8.99M | $8.71M | $8.45M | $2.21M |
| Total current liabilities | $56.98M | $57.53M | $39.03M | $36.49M | $33.43M | $22.66M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $61.03M | $62.14M | $44.36M | $41.91M | $36.42M | $26.00M |
| Retained earnings | -$546.27M | -$503.30M | -$437.59M | -$375.93M | -$292.62M | -$258.64M |
| Total equity | $1.45B | $770.02M | $772.08M | $824.64M | $896.80M | $921.03M |